Skip to main content

Polish startup DIABETOMAT, with a revolutionary solution for diabetics, is preparing for its NewConnect debut.

Step 1 of 2

Let me know,
when the sale starts

I prefer SMS

I prefer eMail

Consent(Required)

Let me know,
when the sale starts

News

Filter

Diabetomat on Good Morning TVN

Read More

Medical Doctor Pawel Kacprzak Medical Director of AME S.A..

Read More

International quality certification for AME S.A. – ISO 13485:2016 awarded!

Read More
Show all

Press about us

AME’s Innovative Medical Technologies – Revolutionizing Diabetes and Heart Failure Diagnostics

November 6, 2024 Read More

Diagnosis of diabetes and heart failure. AME with global potential

November 6, 2024 Read More

Polish startup AME begins clinical trials for Diabetomat and develops Cardio Breath

November 5, 2024 Read More

AME to begin clinical trials of Diabetomat. Proprietary technology to be used in heart failure study with Cardio Breath device

November 5, 2024 Read More

AME will start clinical trials of Diabetomat. Proprietary technology will be used in the study of heart failure with Cardio Breath device

November 5, 2024 Read More

AME to launch Diabetomat clinical trials, utilizing its proprietary technology in a heart failure study with the Cardio Breath device.

November 5, 2024 Read More

AME to launch Diabetomat clinical trials, utilizing its proprietary technology in a heart failure study with the Cardio Breath device.

October 30, 2024 Read More

AME to Begin Clinical Trials of Diabetomat

October 29, 2024 Read More

AME to begin clinical trials of Diabetomat. The technology will also be used in the CardioBreath device

October 29, 2024 Read More

AME seeks funding for the CardioBreath project

October 22, 2024 Read More

Weekly review of ISBzdrowie and ISBnews from the medical and biotech market

October 21, 2024 Read More

Listed startup AME is adding a second business pillar. It’s developing a device for diagnosing heart failure.

October 21, 2024 Read More

Weekly review of ISBzdrowie and ISBnews from the medical and biotech market

October 21, 2024 Read More

Listed startup AME adds a second business pillar

October 21, 2024 Read More

AME applies for funding for the CardioBreath project under the SMART track

October 18, 2024 Read More

AME applies for funding for the CardioBreath project under the SMART track

October 18, 2024 Read More

Polish startup AME revolutionizes diabetes care – non-invasive glucometer coming soon.

October 14, 2024 Read More

Polish Startup battles Diabetes: Diabetomat nears NewConnect debut

September 30, 2024 Read More

Polish start-up fighting diabetes: Diabetomat approaches NewConnect debut

September 30, 2024 Read More

Impressive AME Debut on NewConnect

September 23, 2024 Read More

Advanced Medical Equipment (AME) on NewConnect: Investors React Enthusiastically to Debut

September 23, 2024 Read More

Stock price rising like sugar after donuts. Rocket debut on the stock exchange

September 23, 2024 Read More

AME DEBUTS ON NEWCONNECT (INTERVIEW)

September 23, 2024 Read More

Medical startup to debut on NewConnect

September 20, 2024 Read More

Advanced Medical Equipment to debut on NewConnect

September 20, 2024 Read More

Advanced Medical Equipment to request NewConnect debut date

September 13, 2024 Read More

Breakthrough in diabetes treatment. Poles invented a revolutionary device for patients

September 13, 2024 Read More

AME and Diabetomat Debut on NewConnect

September 12, 2024 Read More

Advanced Medical Equipment to request debut date on NewConnect

September 12, 2024 Read More

Advanced Medical Equipment to request debut date on NewConnect

September 12, 2024 Read More

Advanced Medical Equipment to request debut date on NewConnect

September 12, 2024 Read More

AME and Diabetomat Debut on NewConnect: A New Era in Diabetes Treatment

September 12, 2024 Read More

An opportunity for millions of diabetics in Poland. The company awaits its stock market debut.

September 12, 2024 Read More

Professors Go to NewConnect

September 12, 2024 Read More

Polish startup with a revolutionary solution for diabetics, DIABETOMAT, is set to debut on NewConnect.

August 19, 2024 Read More

Polish start-up fighting diabetes: Diabetomat approaches NewConnect debut

August 19, 2024 Read More

Diabetomat will change the lives of diabetics, it will be a revolution, that’s what they’re writing

August 19, 2024 Read More

Advanced Medical Equipment S.A. – Polish innovator on the road to global success

August 19, 2024 Read More

Polish startup fighting diabetes: Diabetomat nears NewConnect debut

August 19, 2024 Read More

Medical start-ups in demand on financial markets

August 18, 2024 Read More

Non-invasive Diabetomat a breakthrough for diabetics?

August 16, 2024 Read More

Advanced Medical Equipment nearing its NewConnect debut

August 14, 2024 Read More

Hope for diabetics. Poles invented an affordable, non-invasive glucometer

August 13, 2024 Read More

Polish startup DIABETOMAT, with a revolutionary solution for diabetics, is preparing for its NewConnect debut.

August 13, 2024 Read More

Polish startup AME to debut on NewConnect. It has created Diabetomat – a revolutionary solution for diabetics

August 13, 2024 Read More

Advanced Medical Equipment plans to debut on NewConnect in September

August 13, 2024 Read More

Advanced Medical Equipment plans to debut on NewConnect in September

August 13, 2024 Read More

Advanced Medical Equipment plans to debut on NewConnect in September

August 13, 2024 Read More

Advanced Medical Equipment plans to debut on NewConnect in September

August 13, 2024 Read More

Advanced Medical Equipment plans to debut on NewConnect in September

August 13, 2024 Read More

This could be a global hit. Poles have created a revolutionary non-invasive glucometer

August 13, 2024 Read More

From a scientific perspective

Learn the details of how
Diabetomat works in practice.

Investor Zone

Progress on
launch of Diabetomat
.

For the media

Contact

kontakt@diabetomat.pl

For the investor:

inwestor@diabetomat.pl

Contact Us

© 2023 Diabetomat. Privacy Policy

The website
is nurtured by: